‡ In these countries please contact our distributor


Silver-coated Antimicrobial Barrier Dressing



ACTICOAT Site is an antimicrobial absorbent 3-layer dressing consisting of the following:

  • A nanocrystalline silver-coated polyurethane wound contact layer
  • a white polyurethane foam layer and
  • a blue waterproof polyurethane film layer

The dressing provides an effective barrier to microbial contamination protecting the insertion site from invasive pathogenic microorganisms. Nanocrystalline silver is also effective against micro-organisms present in the wound.


Indicated for use in light to moderately exuding partial thickness wounds including decubitus ulcers, 1st and 2nd degree burns, and donor sites. May be used over debrided and partial thickness wounds.


  • Do not use on patients with a known sensitivity to silver
  • Do not use on patients with a known sensitivity to polyurethane
  • Do not use on patients during MRI (Magnetic Resonance Imaging) examination because the image at the dressing site may be distorted


  • For external use only
  • ACTICOAT Site is not compatible with oil-based products such as petrolatum
  • ACTICOAT Site may not be compatible with topical antimicrobials
  • ACTICOAT Site is not compatible with oxidising agents (eg. EUSOL) as these can breakdown the absorbent polyurethane component of the dressing
  • Avoid contact with electrodes or conductive gels during electronic measurements eg. EEG and ECG
  • Prior to administering radiation therapy, remove ACTICOAT◊ Site. A new dressing can be applied following treatment
  • If reddening or sensitisation occurs, discontinue use
  • ACTICOAT Site should be removed prior to X-ray as it may obscure imaging

Ordering Codes / Reimbursement Information

Product# Size Pcs/
20611 1 disk with 4mm central opening 10 10 A4221, A4913, B4034, B4035, or B4036*
A4221, B4034, B4035, or B4036**

*This is one component of a supply kit. Refer to DME MAC Enteral Nutrition Policy Article for information on other items that are included in codes B4034, B4036. Invalid for submission to DMERC. 

**This is one component of a supply kit. When used for enteral nutrition, refer to DME MAC enteral nutrition policy article for information on the other items that are included in codes B4034-B4036. When used with infusion pump. refer to DME MAC external infusion pumps policy article for information on other items that are included in code A4221.

Instructions for Use

Step 1

Where required, cleansing of the skin using sterile water around the wound should be performed according to local clinical protocol. Saline should not be used.

Step 2


Remove the ACTICOAT Site dressing from the pack using an aseptic technique. The dressing should not be moistened prior to use.

Step 3


Apply ACTICOAT Site aseptically around the inserted device so that the device is completely surrounded by the dressing. The silver layer should be in contact with insertion site and the blue side of the dressing away from the skin. Ensure that the pre-cut slit is oriented near or under the inserted device and that the edges of the slit meet to allow full contact with the surrounding skin.

Step 4


Secure the dressing with an appropriate secondary retention dressing, e.g. IV3000.

Step 5


Remove film dressing and ACTICOAT Site dressing in one piece by stretching the film parallel to the patients skin while stabilising the the patients skin and catheter with hand. Alternatively, where using IV3000, use an alcohol wipe to break the adhesive seal. Notes:

  • Only one dressing should be applied to the insertion site.
  • Occasionally transient pain on application of ACTICOAT has been reported. This can be minimised by carefully following the application instructions.
  • Should continuous pain be experienced after application remove the dressing and discontinue use.
  • The dressing may be left in place for up to 7 days, but will require earlier changing if a strike through of exudate occurs.
  • If the dressing adheres to the insertion site, moisten or soak to assist removal and avoid disruption of the insertion site.
  • ACTICOAT Site may cause transient discolouration of the surrounding skin.